
Ergagin 0.125mg Tablet
Marketer
Mercury Laboratories Ltd
Salt Composition
Methylergometrine (0.125mg)
Overview Ergagin 0.125mg Tablet
Uterine bleeding following childbirth or termination of pregnancy may be managed with Ergagin 0.125mg tablets. This medication enhances uterine muscle tone, contraction frequency, and strength, thereby minimizing blood loss. Ergagin 0.125mg tablets may be ingested with or without food; however, consistent timing optimizes efficacy. Adhere strictly to your physician's prescribed dosage and regimen, tailored to your specific condition and response. Swallow the tablets whole with water. Continue treatment for the duration specified by your doctor. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or persistent side effects to your physician; management strategies may be available. Alcohol consumption is generally discouraged during treatment. Prior to commencing treatment, disclose any history of heart disease or hypertension, and provide a comprehensive list of all other medications you are currently using, as interactions can affect Ergagin's potency or mechanism of action.
Uses of Ergagin 0.125mg Tablet
Hemorrhage postpartum
Major Benefits of Ergagin 0.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 0.125mg Ergagin tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Ergagin 0.125mg Tablet:
- High blood pressure
- Headache
- Seizure
How to use Ergagin 0.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 0.125mg Ergagin tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Ergagin 0.125mg Tablet works:
Ergagin 0.125mg tablets contain an ergot alkaloid that induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ergagin 0.125mg Tablets lacks established safety data. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ergagin 0.125mg tablets during pregnancy poses a serious risk. Pregnant women should consult their physician; research in animals and pregnant humans indicates substantial harm to the fetus.
Breast feedingCAUTION
The use of Ergagin 0.125mg tablets necessitates careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Ergagin 0.125mg Tablets is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Ergagin 0.125mg Tablet use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Ergagin 0.125mg tablets to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Ergagin 0.125mg Tablet :
Should you forget a dose of Ergagin 0.125mg Tablet, take it immediately if you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ergagin 0.125mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Ergoline Alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Active Class | Drugs that induce or terminate pregnancy |
